RE:RE:CDC flip flopsAll 4 of DM's kits are nucleic acid tests for detecting active virus infections. HC Canada only recently decided to give serological or anti-body tests consideration. The most conclusive way to test is to do both, IMO. Cost prohibitive maybe? Employers will go with nucleic acid tests IMO.
Some 16 million of the options remaining are at .17 I am hoping remaining warrant holders are out of the picture. We have endured dilution long enough, time for good news and a price run. Millions of warrants wouldn't have been exercised if holders weren't confident in DM's future SP holding for 4 months. More patience required? If that is managements opinion, they misread market sentiment, IMO.
(Canadian dollars, except share and unit information) 7 Exercise of Share Options and Warrants Subsequent to the period end, the Company has received $493,500 from the exercise of share purchase options at $0.05 and $0.07 per share and issued 8,750,000 common shares.
Subsequent to the period end, the Company has received $1,229,184 from the exercise of share purchase warrants at $0.08 per share and issued 15,364,800 common shares.
Outstanding Share Information The Company is authorized to issue an unlimited number of common shares with no par value. As at the date this discussion and analysis is prepared, the Company had 257,816,361 shares outstanding, 25,650,000 share options outstanding and 7,244,000 warrants outstanding